PMID- 12375636 OWN - NLM STAT- MEDLINE DCOM- 20021024 LR - 20041117 IS - 0002-9173 (Print) IS - 0002-9173 (Linking) VI - 118 IP - 4 DP - 2002 Oct TI - Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors. PG - 512-7 AB - Differentiation of dysembryoplastic neuroepithelial tumor (DNT) from cystic low-grade oligodendroglioma, particularly in a limited biopsy orfragmented specimen, may be impossible. Research has shown that allelic loss of chromosome 1p is a relatively common finding in oligodendrogliomas. Little is known about chromosome 1p status in DNT. We retrospectively evaluated 14 DNTs for loss of heterozygosity (LOH) on chromosome 1p by fluorescence in situ hybridization (FISH) and compared the results with 1p FISH analysis in 57 low-grade oligodendrogliomas (World Health Organization grade II). The 14 DNTs arose in 8 females and 6 males (mean age, 20.9 years at the time of surgery). All 14 DNTs were 1p intact by FISH analysis. The 57 low-grade oligodendrogliomas arose in 31 males and 26 females (mean age, 43.2 years). LOH on chromosome 1p was present in 31 (54%) of 57 tumors; the remaining 26 tumors were 1p intact. LOH on chromosome 1p is not a feature of DNTs. LOH on chromosome 1p may be a useful differential diagnostic feature (favoring oligodendroglioma) in a subset of cases in which specimen fragmentation or size raises the differential diagnosis of DNT vs oligodendroglioma. FAU - Prayson, Richard A AU - Prayson RA AD - Department of Neurological Surgery, Cleveland Clinic Foundation, OH 44195, USA. FAU - Castilla, Elias A AU - Castilla EA FAU - Hartke, Marybeth AU - Hartke M FAU - Pettay, James AU - Pettay J FAU - Tubbs, Raymond R AU - Tubbs RR FAU - Barnett, Gene H AU - Barnett GH LA - eng PT - Journal Article PL - England TA - Am J Clin Pathol JT - American journal of clinical pathology JID - 0370470 SB - IM MH - Adolescent MH - Adult MH - Brain Neoplasms/*genetics/pathology MH - Child MH - *Chromosomes, Human, Pair 1 MH - Diagnosis, Differential MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Loss of Heterozygosity/*genetics MH - Male MH - Middle Aged MH - Neoplasms, Neuroepithelial/*genetics/pathology MH - Oligodendroglioma/genetics/pathology MH - Teratoma/*genetics/pathology EDAT- 2002/10/12 04:00 MHDA- 2002/10/31 04:00 CRDT- 2002/10/12 04:00 PHST- 2002/10/12 04:00 [pubmed] PHST- 2002/10/31 04:00 [medline] PHST- 2002/10/12 04:00 [entrez] AID - 10.1309/KLAG-TARW-WDBJ-5CTJ [doi] PST - ppublish SO - Am J Clin Pathol. 2002 Oct;118(4):512-7. doi: 10.1309/KLAG-TARW-WDBJ-5CTJ.